Presentation of the Centre

Karolinska CCC brings together cutting-edge expertise in research and cancer care. The centre is a joint initiative within Karolinska University Hospital and Karolinska Institutet. The centre has a significant role in the development of health care where new research findings and new treatment methods are continuously implemented to benefit the patients.

Main Research Activities

Research covers all fields from molecular mechanisms and DNA repair to multidisciplinary cancer research and clinical studies. Cancer Research KI is an overarching umbrella organisation and includes 250 research groups covering the entire spectrum from basic to clinical research, epidemiology, and care sciences The aims are to improve prevention strategies, develop better prognostication and therapy prediction to improve tailoring of therapies, development of new therapies aiming at decreased morbidity, better care, and decreased mortality.

Core Facilities

The centre offers a wide spectrum of research core facilities: Clinical trial Unit, Phase 1 and CTO, Center for Cell therapies, Proteomics, Genomics transcriptomics, , etc. SciLifeLab combines frontline technical expertise with advanced knowledge of translational medicine and molecular bioscience.

Education

There are 16 programs to train medical staff, at the undergraduate level the teaching in cancer is integrated in the general programs for professional training. Specialist training is provided in cancer-related disciplines and continuing professional development is also an important part. From the master level and onward oncology and cancer biology are specific topics for doctoral programs and courses.

Presentation of the Centre

Skane University Hospital Comprehensive Cancer Centre (SUHCCC) is a partnership between Skane University Hospital (located in Malmö and Lund), Lund University, Regional Cancer Centre South, Medical Services and Mobile Teams/Specialized Palliative Care within Primary Care. SUHCCC works to promote clinical research, faster access to new treatment methods for patients with cancer, patient participation and even higher quality of cancer care through a more structured partnership. Skåne University Hospital is one of the largest cancer-treating hospitals in the Nordic region and provides national and regional specialized care in South Sweden, covering a population of 1.8 million people. SUHCCC structure promote continuous improvement as well as international and national networking.

Main Research Activities

SUHCCC integrates research into clinical practice, enhances collaboration from prevention to palliative care, with key areas including genomics, proteomics, biomarkers, novel therapies and clinical trials.

Core Facilities

Core facilities include for example regional cancer registries, a biobank, a oncology/hematology clinical trial unit, molecular diagnostics, advanced gene and cell therapy as well as a comprehensive radiotherapy centre with inhouse MRI, MR-Linac, SRS/SBRT, orthovoltage- brachy- and tomotherapy.

Education

Education for all categories of healthcare professionals in various cancer-related disciplines is an important mission for SUHCCC. The university and hospital are responsible for the teaching of students within a range of professions, including medical students, hospital physicists and nurses. SUHCCC also provides a number of further educational initiatives as well as education directed at patients and next of kin.

Presentation of the Centre

Uppsala Comprehensive Cancer Centre (UCCC) aims to be one of the leading cancer centers in Europe focusing on the patient. Our university hospital is responsible for cancer care in a 2 million people region and is a national and international referral center. We provide cutting-edge, multidisciplinary cancer care, with excellent facilities for medical imaging, biomarker measurement and genetic diagnostics. Our center is dedicated to provide the best and most up-to-date personalized treatment, including surgery, medical oncology and radiotherapy as well as palliative care and rehabilitation.

Main Research Activities

Successful cancer research from bench to bedside is carried out in close collaboration with Uppsala University. We have a JACIE accreditation of stem cell transplantation and the only Swedish ENETS and ERN center of excellence for Neuroendocrine tumors. Through our ATMP center translational research, clinical trials and development of new CAR-T cells is in the forefront. The Skandion Clinic in Uppsala provides excellent possibilities for research on proton beam radiotherapy.

Core Facilities

Our Clinical Research and Development Unit provides top-level support for clinical trials. The U-CAN collection of longitudinal tumor and blood samples comprise > 8000 cancer patients in the Uppsala biobank. SciLifeLab provides access to cutting-edge research core facilities for e.g. omics, imaging and drug discovery. The EpiHub supports excellent epidemiology research.

Education

We provide education of health care professions both at undergraduate, master and specialized levels and have an extensive PhD program.

Presentation of the Centre

Sahlgrenska University Hospital was founded in 1782 and is today one of the largest in Northern Europe with approximately 16 700 employees. Our oncology department dates back to 1943, when a royal donation enabled the construction of several dedicated clinics for cancer care in Sweden. Today Sahlgrenska Comprehensive Cancer Centre acts as the regional cancer hub for Region Västra Götaland, serving 1,7 million inhabitants. We treat all forms of cancer, including paediatric and apart from our regional assignment, we also hold national responsibilities for treatment of several rare cancer diseases.

Main Research Activities

Research at Sahlgrenska CCC is a collaborative effort between the University Hospital and the Sahlgrenska Academy at the University of Gothenburg. This partnership spans a wide range of cancer research, from basic to translational and clinical studies. Our ongoing research activities consistently produce high-impact publications. In 2018, a national evaluation confirmed our top position in clinical research in Sweden. As of 2019, we have over 80 active cancer trials at our clinical trials unit. Additionally, we engage in numerous intense international collaborations across various research areas.

Core Facilities

We have a dedicated center for translational cancer research and a genomics center. Sahlgrenska CCC is also an integral part of the hospital Precision Medicine Center. Additionally, we boast a specialized imaging center equipped with the latest MRI and PET technology, along with a cyclotron to produce specific nuclides for our PET cameras. Our radiotherapy department currently operates ten linear accelerators, with plans to expand to thirteen.

Education

Sahlgrenska University Hospital is involved in the education of medical students, PhD students, cancer physicians and oncology nurses. Education is of high priority and is performed in close cooperation with Sahlgrenska Academy.

Presentation of the Centre

Linköping Comprehensive Cancer Center (LCCC) is a leading hub for cancer research, patient care, and education located in Linköping, Sweden. Dedicated to cancer prevention, diagnosis, and treatment, LCCC integrates cutting-edge research with clinical expertise to improve outcomes for patients regionally and globally.

Main Research Activities

LCCC focuses on a broad spectrum of cancer research, including molecular and cellular mechanisms of cancer, biomarker discovery, immunotherapy, and precision medicine. Translational research bridges laboratory findings with clinical applications, ensuring that innovations directly benefit patients. The center also prioritizes epidemiological studies to better understand cancer risk factors and develop preventative strategies.

Core Facilities

LCCC boasts state-of-the-art core facilities that support its research mission. These include advanced genomics and proteomics platforms, imaging technologies, and biobanking services. The integration of artificial intelligence and big data analytics enables researchers to analyze complex datasets for personalized cancer treatments. Close collaboration between the University and the University Hospital provides access to clinical trials and cutting-edge therapies.

Education

The center is deeply committed to education, offering specialized training programs for students, clinicians, and researchers. These include doctoral studies, postdoctoral training, and continuing education for healthcare professionals. LCCC actively fosters interdisciplinary collaboration, nurturing the next generation of cancer experts through mentorship and research opportunities. By uniting research, clinical care, and education, LCCC plays a pivotal role in the fight against cancer.

Presentation of the Centre

Örebro University Hospital, including highly specialised care and primary care is the centre of all cancer care in Region Örebro County. It’s a no-profit public organisation run by elected representatives. The centre offers multidisciplinary cancer care for all major cancer diseases, and it is a referral centre for patients from Healthcare region mid-Sweden in selected areas including cancer surgery as well as other oncological procedures. Within the area of penile cancer, it is one of two centres for national highly specialised care.

Main Research Activities

There is a long-standing research commitment in major disease areas i.e. breast and prostate cancer including other urogenital cancers, HPV related cancers, ENT cancer and melanoma. Clinical research using a range of methods including laboratory, epidemiological, registry based, qualitative as well as randomized studies are included in the patient centred research approach. Recently, artificial intelligence, advanced imaging and front-line omnic methods have been added to the methodological portfolio. There is a close collaboration with Örebro University in cancer research.

Core Facilities

Within the research facilities for both the University and the Hospital there are a broad range of support competence including data management, epidemiology, clinical trial units, ATMP facility and advanced imaging and omnic technologies. There are hubs within national collaborative research infrastructures including Clinical Genomics laboratory, Genomic Medicine Centre, Örebro biobank and precision medicine. CAR-T therapy has recently been introduced at the university hospital. Region Örebro County is one of seven stakeholders in the national proton therapy facility.

Education

Örebro University and Region Örebro County/Örebro University Hospital have a longstanding collaborating concerning several educational programs for health professions including nurses, biomedical scientist, occupational therapist and medical school. PhD programs are available in biomedicine, healthcare science, medicine and surgery. Post graduate education for medical doctors is established in almost all specialities relevant to cancer care and cancer research.

Presentation of the Centre

The Umeå University Hospital (applying to be Umeå CCC) is the referral center for cancer treatment in the northern health care region of Sweden comprising more than 50% of Sweden’s geographical area and with a catchment area of 1 million inhabitants. The university hospital cares for diagnosis and treatment for all major cancer diseases.

Main Research Activities

The integration between the university hospitals and Umeå university is the base for our strong pre-clinical, translational and clinical research. Cancer research is one of the focus research areas that includes basic, translational and clinical cancer research. Further, our biobanks and cancer registries enable unique population-based studies including pre-diagnostic blood samples collected in the region.

Core Facilities

The cancer specialized clinical research unit (KFE), the pre-clinical research lab and the radiation oncology research platform including PET/MR facilitates translational cancer research are examples of core facilities. The Clinical Research Center (KFC) is a joint resource for regional clinical studies for the northern health care region.

Education

The Cancer Centre participates is education on all academic levels and have graduate students from most educational programs. Life sciences students are integrating into the core facilities of the Cancer centre. Cancer research education for postgraduate students is given and the Cancer Centre is deeply involved in a national Cancer research school.

Presentation of the Institute

In the heart of Stockholm lies Capio St Göran’s Hospital. We diagnose and treat approximately one third of all breast, prostate, and colon cancer cases in the Greater Stockholm area, and we also provide specialised haematology services.

Capio St Göran’s Hospital is unique in Sweden as the country’s only privately operated, publicly funded emergency hospital. We have been part of Capio for more than 26 years and are now part of Ramsay Santé, within Ramsay Health Care.

Core Facilities and Main Research Activities

We are affiliated with Karolinska Institutet and have an on-site research facility with around 20 ongoing clinical studies.

During the past year, approximately 40 scientific papers related to cancer and cancer treatment were published by our teams.

Education

We also contribute to the education and training of medical students, nursing students, and junior doctors in collaboration with Karolinska Institutet.

Presentation of the Network

Nätverket mot cancer (NMC) is an umbrella organisation consisting of 12 national and two regional cancer profiled patient organisations, in total approximately 40,000 individual members. NMC is based in Stockholm.

The Council has been nominated by the member societies and the General Assembly of Delegates vote for the Council members. The Council consists of patients and persons with experience of cancer in their families and relatives, “next-of-kin”.

The vision for NMC is “a society without cancer”. NMC works for implementing EU Beating Cancer Plan in Sweden: cancer prevention/screening, care, innovation, research, rehabilitation, palliative care and the best possible quality of life from investigation to palliative care. We are members of the Government´s Patient Council, governmental expert committees for CCI, ECHoS, Digital Infrastructure, EU Beating Cancer Plan and a Swedish National Cancer Strategy.

We arrange World Cancer Day and produce a Cancer Report every year to document our work for better research and care. We are involved in research projects, health care development and collaborate with professionals, care givers and researchers. We are partners in Vision Zero Cancer and Testbed Sweden Precision Health Cancer. We Co-lead EU-CIP (ECPDC) WP7 citizens and community and are members of the Advisory Board of EU-AMB@R, digital rehabilitation and of the Strategic Committee of Sahlgrenska University Hospital.

We work with our member societies for screening, vaccination, early detection, precision medicine and precision health, the best possible quality of life from investigation to palliative care and with patient advocacy training. Board members have experience from cancer treatment, a life after or with cancer. Most Council members have university and management backgrounds.